JPWO2022092277A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022092277A5 JPWO2022092277A5 JP2022559269A JP2022559269A JPWO2022092277A5 JP WO2022092277 A5 JPWO2022092277 A5 JP WO2022092277A5 JP 2022559269 A JP2022559269 A JP 2022559269A JP 2022559269 A JP2022559269 A JP 2022559269A JP WO2022092277 A5 JPWO2022092277 A5 JP WO2022092277A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- receptor
- leukemia
- protein
- car
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063107027P | 2020-10-29 | 2020-10-29 | |
| PCT/JP2021/040069 WO2022092277A1 (ja) | 2020-10-29 | 2021-10-29 | Ｃｘｃｌ１２受容体発現キメラ抗原受容体（ｃａｒ）－ｔ細胞 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022092277A1 JPWO2022092277A1 (https=) | 2022-05-05 |
| JPWO2022092277A5 true JPWO2022092277A5 (https=) | 2024-11-05 |
Family
ID=81384080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559269A Pending JPWO2022092277A1 (https=) | 2020-10-29 | 2021-10-29 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240041925A1 (https=) |
| EP (1) | EP4239062A4 (https=) |
| JP (1) | JPWO2022092277A1 (https=) |
| CN (1) | CN116887845A (https=) |
| WO (1) | WO2022092277A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12006353B2 (en) * | 2022-07-25 | 2024-06-11 | Long Chen | Application of SCFV protein, car gene expression vector, CAR-T cell and application thereof |
| WO2025106626A1 (en) * | 2023-11-15 | 2025-05-22 | Century Therapeutics, Inc. | Genetically engineered cells expressing c-x-c chemokine receptor type 4, and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6839074B2 (ja) * | 2014-09-17 | 2021-03-03 | ノバルティス アーゲー | 養子免疫療法のためのキメラ受容体での細胞毒性細胞のターゲティング |
| GB201522223D0 (en) * | 2015-12-16 | 2016-01-27 | Ucl Business Plc | Therapeutic T cells |
| JP2019529423A (ja) | 2016-09-15 | 2019-10-17 | 国立研究開発法人理化学研究所 | 急性骨髄性白血病を処置するためのＨＣＫ阻害剤及びＢｃｌ−２阻害剤 |
| US11427633B2 (en) * | 2016-12-13 | 2022-08-30 | Crage Medical Co., Limited | Anti-CD19 humanized antibody and immune effector cell targeting cd 19 |
| ES2912408T3 (es) * | 2017-01-26 | 2022-05-25 | Novartis Ag | Composiciones de CD28 y métodos para terapia con receptores quiméricos para antígenos |
| CN109666074B (zh) * | 2018-12-29 | 2020-04-24 | 广州百暨基因科技有限公司 | 一种趋化因子受体cxcr5的用途 |
-
2021
- 2021-10-29 CN CN202180088217.0A patent/CN116887845A/zh active Pending
- 2021-10-29 EP EP21886394.2A patent/EP4239062A4/en active Pending
- 2021-10-29 US US18/034,621 patent/US20240041925A1/en active Pending
- 2021-10-29 WO PCT/JP2021/040069 patent/WO2022092277A1/ja not_active Ceased
- 2021-10-29 JP JP2022559269A patent/JPWO2022092277A1/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cho et al. | Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside | |
| Yamaguchi et al. | Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer | |
| US6652884B2 (en) | Method for the treatment of solid tumors by albumin microparticles incorporating paclitaxel | |
| Moertel et al. | Mitomycin C therapy in advanced gastrointestinal cancer | |
| Gu et al. | Enhancement of Radioprotection and Anti-Tumor Immunity by Yeast-Derivedβ-Glucan in Mice | |
| EP2435041B1 (en) | Therapeutic combination comprising a PLK1 inhibitor and an antineoplastic agent | |
| US12551581B2 (en) | Combination cancer immunotherapy with pentaaza macrocyclic ring complex | |
| JPWO2022092277A5 (https=) | ||
| Mason et al. | Enhancement of tumor radioresponse by docetaxel: involvement of immune system | |
| COHEN et al. | Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study | |
| Kebudi et al. | Oral etoposide for recurrent/progressive sarcomas of childhood | |
| CN111166878B (zh) | 靶向肿瘤抗原的抗体与iNKT细胞的组合的制备方法与用途 | |
| RU2348413C2 (ru) | Противоопухолевые лекарственные составы, содержащие дефибротид, один или в сочетании с другими противоопухолевыми средствами | |
| JP2020508351A5 (https=) | ||
| CN104812400A (zh) | 使用伏拉塞替的组合治疗 | |
| CN119326902A (zh) | 癌症联合治疗的组合物与方法 | |
| Pope et al. | 7-Allyl-8-oxoguanosine (loxoribine) inhibits the metastasis of B16 melanoma cells and has adjuvant activity in mice immunized with a B16 tumor vaccine | |
| US20090214669A1 (en) | Combination anticancer therapy and pharmaceutical compositions therefore | |
| Gundersen et al. | Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced disease | |
| Weltz et al. | Methyl-CCNU, 5-fluorouracil, vincristine, and streptozocin (MOF-STREP) in metastatic colo-rectal carcinoma. | |
| Nakamura et al. | Interactions of human fibroblast interferon with chemotherapeutic agents and radiation against human gliomas in nude mice | |
| Stock et al. | Enhanced radiosensitization with Interferon-α-2b and cisplatin in the treatment of locally advanced cervical carcinoma | |
| CN112770760A (zh) | 降低辐射诱发的毒性的方法和组合物 | |
| Kim et al. | Enhancement of Cytotoxicity of Cisplatin in vitro by Recombinant Human Tumor Necrosis Factor and/or Recombinant Human Interferon‐α, β and‐γ | |
| DeJoy et al. | Attenuation of interleukin 2-induced pulmonary vascular leak syndrome by low doses of oral methotrexate |